Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Perrone

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|August 14, 2025
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based ReviewAndrea Pilato, Giorgio D'Avanzo, Francesca Di Nunzio, et al.
Pathologica|January 5, 2024
Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancerCaterina Marchiò, Carmen Criscitiello, Cristian Scatena, et al.
Pathologica|April 9, 2026
Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancerUmberto Malapelle, Simonetta Buglioni, Isabella Castellano, et al.
Journal of Cellular Physiology|June 26, 2010
PML down-regulation in soft tissue sarcomasBruno Vincenzi, Giuseppe Perrone, Daniele Santini, et al.
Clinical Lung Cancer|January 18, 2026
Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature ReviewFabrizio Citarella, Emanuele C Mingo, Matteo Fiorenti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapyKazuyuki Kawakami, Francesco Graziano, Go Watanabe, et al.
International Journal of Molecular Sciences|June 19, 2024
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease PatientsMichele Cicala, Manuele Gori, Paola Balestrieri, et al.
World Journal of Gastroenterology|January 21, 2006
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumorPaola Mazzarelli, Paola Parrella, Davide Seripa, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patientsBruno Vincenzi, Alice Zoccoli, Gaia Schiavon, et al.
Oncotarget|April 19, 2015
Deregulation of dicer and mir-155 expression in liposarcomaBruno Vincenzi, Michele Iuliani, Alice Zoccoli, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|August 14, 2025
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based ReviewAndrea Pilato, Giorgio D'Avanzo, Francesca Di Nunzio, et al.
Pathologica|January 5, 2024
Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancerCaterina Marchiò, Carmen Criscitiello, Cristian Scatena, et al.
Pathologica|April 9, 2026
Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancerUmberto Malapelle, Simonetta Buglioni, Isabella Castellano, et al.
Journal of Cellular Physiology|June 26, 2010
PML down-regulation in soft tissue sarcomasBruno Vincenzi, Giuseppe Perrone, Daniele Santini, et al.
Clinical Lung Cancer|January 18, 2026
Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature ReviewFabrizio Citarella, Emanuele C Mingo, Matteo Fiorenti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapyKazuyuki Kawakami, Francesco Graziano, Go Watanabe, et al.
International Journal of Molecular Sciences|June 19, 2024
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease PatientsMichele Cicala, Manuele Gori, Paola Balestrieri, et al.
World Journal of Gastroenterology|January 21, 2006
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumorPaola Mazzarelli, Paola Parrella, Davide Seripa, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patientsBruno Vincenzi, Alice Zoccoli, Gaia Schiavon, et al.
Oncotarget|April 19, 2015
Deregulation of dicer and mir-155 expression in liposarcomaBruno Vincenzi, Michele Iuliani, Alice Zoccoli, et al.
Pageof 12